111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China.
| Revenue (Most Recent Fiscal Year) | $1.80B |
| Net Income (Most Recent Fiscal Year) | $-9.65M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 0.02 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | -- |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -0.38% |
| Net Margin (Trailing 12 Months) | -0.76% |
| Return on Equity (Trailing 12 Months) | -- |
| Return on Assets (Trailing 12 Months) | -3.80% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.08 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.49 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | -- |
| Inventory Turnover (Trailing 12 Months) | 9.66 |
| Book Value per Share (Most Recent Fiscal Quarter) | $-11.74 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | $-1.40 |
| Exchange | NASDAQ |
| Sector | Consumer Defensive |
| Industry | Pharmaceutical Retailers |
| Common Shares Outstanding | 8.79M |
| Free Float | 4.93M |
| Market Capitalization | $36.28M |
| Average Volume (Last 20 Days) | 0.03M |
| Beta (Past 60 Months) | 0.63 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 43.90% |
| Percentage Held By Institutions (Latest 13F Reports) | 21.32% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |